ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Cardiac Rhythmology
Regional and Racial Outcomes in Mortality after Atrial Fibrillation Ablation in Medicare Fee for Service Patients
Venkata Andukuri 1,2
Dannie Dilsaver 1
Ryan Walters 1
Liou Xu 3
Gary Puckrein 3
Michael H Kim 1,2
1. School of Medicine, Creighton University, Omaha, United States
2. CHI Health Creighton University Medical Center, Omaha, United States
3. National Minority Quality Forum, Washington, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: Catheter ablation of Atrial Fibrillation (AF) is a cornerstone of treatment. Data on regional and racial variations in AF ablation procedural mortality are limited. Methods: Data were abstracted from the 2016-2019 Medicare Fee for Service database (FFS), including inpatient and outpatient visits to evaluate regional and racial differences in 30-day AF ablation mortality in Medicare FFS patients. Patients with an AF diagnosis who had AF ablation were identified via ICD-10, CPT, and MS-DRG codes. The primary outcome was between-region (Northeast, Midwest, South, West) differences in 30-day mortality which was assessed using logistic regression models; multivariable models controlled for race, comorbid COPD, and CHA2DS2-VASc score. Results: 38,477 inpatient and 128,544 outpatient AF ablations met inclusion criteria. AF ablation was most common in the South (inpatient: 17,415, outpatient: 55,932) and least in the Northeast which had a 28% lower adjusted odds of 30-day mortality following inpatient AF ablation compared to the South (NE: 1.75.% vs. S: 2.55%; aOR: 0.72, 95% CI: 0.60-0.88) and 23% lower adjusted odds compared to the West (NE: 1.75% vs. W: 2.30%; aOR: 0.81, 95% CI: 0.66-0.99). In outpatients, the Northeast had 44% lower adjusted odds of 30-day mortality compared to the West (NE: 0.15% vs W:0.25%; aOR 0.56, 95% CI: 0.36-0.87) and the West had a 73% greater odds of 30-day mortality compared to the South (W: 0.25% vs. S: 0.16%; aOR: 1.73, 95% CI: 1.27-2.36). Nonwhite patients had higher mortality in the outpatient cohort. Conclusions: Within this Medicare FFS population, significant variations in mortality exist following AF ablation when analyzed across different regions and race. Further research on potential systemic and patient level factors would be of value to help elucidate why these differences are present.
Summary
Keywords
ablation, Atrial Fibrillation, Medicare, Mortality, outcomes
Received
03 July 2025
Accepted
14 January 2026
Copyright
© 2026 Andukuri, Dilsaver, Walters, Xu, Puckrein and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Michael H Kim
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.